Look beyond the plus sign
The Estriol+ product page names estriol, DMAE and hyaluronic acid in its explanation of the formula. That ingredient combination is different from a plain moisturizer, and it is also different from every other estriol preparation by default. The full prescription details should be confirmed directly rather than inferred from the product name.
Ask for the concentration of each active and the complete ingredient list for the formulation you would receive. A public marketing description may identify the ingredients without supplying all the information needed to compare strength, base or potential irritants. Marking a field “confirm with the prescriber” is more useful than filling a gap with another brand’s formula.
The clinic presents the cream in relation to changes associated with menopause. A useful consultation still considers other explanations for a skin concern. New or persistent irritation, a changing lesion and generalized dryness are not interchangeable problems. Our consultation guide explains how to describe what changed before deciding which ingredient to seek.
The public price covers a stated supply
Midi displayed $149 for a 90-day supply totaling 90 mL when checked. Its Custom Rx Express page describes three 30 mL pump dispensers. This is a supply price; dividing it into an approximate monthly equivalent does not change the amount associated with the order.
Do not turn the stated volume and supply period into self-directed dosing. A prescription label and clinician instructions determine use. Someone’s treatment may change before the advertised supply is finished, and using more to match a marketing timeline is not a meaningful way to assess a medicine.
Ask whether the displayed price includes the evaluation, shipping and all follow-up connected to the prescription. Also ask whether the order renews automatically. The face-cream offer should not be assumed to include every service available through Midi’s broader menopause-care clinic. Our comparison page keeps the cream’s stated terms separate from assumptions about the company as a whole.
An online review is still a clinical decision
The product page describes completing a health submission, clinician review and payment charged after approval. Its timeline language says approval usually occurs within 24 hours, while the Custom Rx Express page mentions an approval message within 48 hours. These are differing published estimates, not a commitment we can independently guarantee.
That discrepancy is a good reason to ask about current turnaround if timing matters. It does not justify treating a completed form as approval. Eligibility, the need for more information and state-specific service arrangements may affect what happens next. A prospective patient should know how to contact the service if the application requires follow-up.
The same principle applies to clinician support. “Guidance available” is useful, but it is worth learning how questions are submitted and how care is coordinated with an existing prescriber. Use our question sheet to make a short list before opening an intake, especially if you already use hormone therapy elsewhere.
Keep marketing and measured findings apart
Midi’s page describes benefits involving firmness, hydration and texture, alongside patient testimonials. These are the provider’s claims and selected experiences. We did not identify a trial of the exact Estriol+ finished formula in the public materials reviewed for this article.
That finding is a limit of our review, not proof that no research exists. The useful follow-up is to ask the provider for any product-specific study and determine whether it matches the prescribed formulation. Broader estrogen research can supply context while leaving unanswered questions about a particular mixture, population and duration.
Our estriol research article explains why a study of one cream cannot automatically establish results for another. In the same way, a positive experience reported by a patient with rosacea should not be converted into evidence that Estriol+ treats rosacea. A testimonial’s medical details do not establish an approved indication or a reliable treatment effect.
“Local” needs a careful explanation
Midi’s description emphasizes action in the skin. A reader should ask what supports that statement and what remains uncertain about systemic exposure. Location of application alone does not establish that absorption elsewhere is impossible, nor can a small study rule out every uncommon or long-term outcome.
Provide the clinician with your full medication list, including vaginal and systemic hormones. Discuss relevant cancer history, unexplained bleeding and other issues affecting hormone-related decisions. These are questions for individualized assessment, not a checklist that this review can use to pronounce the cream safe for a particular person.
The FDA states that no estriol-containing drugs are FDA-approved. Its compounding guidance explains why a compounded prescription is not evaluated through the same premarket approval process as an approved drug. Read our regulatory guide for the distinction from recent hormone-therapy labeling news.
What to resolve before choosing
Midi publishes a clear supply amount and an online review pathway. The next conversation should establish the exact formula, the complete payment arrangement and how the prescribing team would assess your circumstances. Those answers are more useful than treating the clinic’s midlife focus as proof of a specific product’s superiority.
Compare the resulting information with Alloy M4, Musely Aging Repair and our sponsored CoreAge Rx review. Include a discussion of non-hormonal options when appropriate. A good decision may involve a prescription, a simpler routine or further evaluation before purchasing anything.